Paszkowska, A.; Kolenda, T.; Guglas, K.; Kozłowska-Masłoń, J.; Podralska, M.; Teresiak, A.; Bliźniak, R.; Dzikiewicz-Krawczyk, A.; Lamperska, K.
C10orf55, CASC2, and SFTA1P lncRNAs Are Potential Biomarkers to Assess Radiation Therapy Response in Head and Neck Cancers. J. Pers. Med. 2022, 12, 1696.
https://doi.org/10.3390/jpm12101696
AMA Style
Paszkowska A, Kolenda T, Guglas K, Kozłowska-Masłoń J, Podralska M, Teresiak A, Bliźniak R, Dzikiewicz-Krawczyk A, Lamperska K.
C10orf55, CASC2, and SFTA1P lncRNAs Are Potential Biomarkers to Assess Radiation Therapy Response in Head and Neck Cancers. Journal of Personalized Medicine. 2022; 12(10):1696.
https://doi.org/10.3390/jpm12101696
Chicago/Turabian Style
Paszkowska, Anna, Tomasz Kolenda, Kacper Guglas, Joanna Kozłowska-Masłoń, Marta Podralska, Anna Teresiak, Renata Bliźniak, Agnieszka Dzikiewicz-Krawczyk, and Katarzyna Lamperska.
2022. "C10orf55, CASC2, and SFTA1P lncRNAs Are Potential Biomarkers to Assess Radiation Therapy Response in Head and Neck Cancers" Journal of Personalized Medicine 12, no. 10: 1696.
https://doi.org/10.3390/jpm12101696
APA Style
Paszkowska, A., Kolenda, T., Guglas, K., Kozłowska-Masłoń, J., Podralska, M., Teresiak, A., Bliźniak, R., Dzikiewicz-Krawczyk, A., & Lamperska, K.
(2022). C10orf55, CASC2, and SFTA1P lncRNAs Are Potential Biomarkers to Assess Radiation Therapy Response in Head and Neck Cancers. Journal of Personalized Medicine, 12(10), 1696.
https://doi.org/10.3390/jpm12101696